| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/02/2009 | WO2009023194A3 Hormone responsive tissue culture system and uses thereof |
| 04/02/2009 | WO2009017321A3 Co-culture method of skin cells and cell therapy composition using the same |
| 04/02/2009 | WO2009015343A3 Differentiation of multi-lineage progenitor cells to chondrocytes |
| 04/02/2009 | WO2009012428A3 Differentiation of human embryonic stem cells |
| 04/02/2009 | WO2009009906A8 Isoflavonoid production in plants |
| 04/02/2009 | WO2008112004A3 ANTIBODIES DIRECTED TO αVβ6 AND USES THEREOF |
| 04/02/2009 | WO2008109668A3 Methods to control cell movement in hollow fiber bioreactors |
| 04/02/2009 | WO2008070171A3 Method for identifying and manipulating cells |
| 04/02/2009 | WO2008021475A3 Compositions and methods for hematopoietic stem cell expansion or for modulating angiogenesis |
| 04/02/2009 | WO2007111952A3 Method of preparing glycopeptides |
| 04/02/2009 | WO2007015691A3 Methods and compositions for increasing longevity and protein yield from a cell culture |
| 04/02/2009 | WO2006060193A3 Compositions and methods for stem cell expansion |
| 04/02/2009 | WO2006044832A3 Device for tissue engineering |
| 04/02/2009 | WO2006034300A3 Great wall kinases and uses thereof |
| 04/02/2009 | WO2006031688A3 Method of separating tumor cells with and without lymphotropic metastatic potential in a human carcinoma |
| 04/02/2009 | WO2006023495A3 Carotenoid hydroxylase enzymes |
| 04/02/2009 | WO2005121323A3 Methods for ex vivo propagation of somatic hair follicle stem cells |
| 04/02/2009 | WO2005096805A3 Cambium/xylem-preferred promoters and uses thereof |
| 04/02/2009 | WO2005089127A3 Polymer-ceramic-hydrogel composite scaffold for osteochondral repair |
| 04/02/2009 | WO2005086860A3 Methods for generating insulin-producing cells |
| 04/02/2009 | WO2005081970A3 Self-assembling cell aggregates and methods of making engineered tissue using the same |
| 04/02/2009 | WO2005033292A3 Methods of establishing intercellular communication in an endothelial cell layer and uses thereof |
| 04/02/2009 | WO2005030930A3 Variants of cyan fluorescent protein with improved fluorescent properties |
| 04/02/2009 | WO2005011569A3 Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
| 04/02/2009 | WO2004080394A3 Stat3 antagonists and their use as vaccines against cancer |
| 04/02/2009 | WO2003087125A3 A novel g protein-coupled purinergic receptor, gave 17 |
| 04/02/2009 | US20090089898 Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby |
| 04/02/2009 | US20090089896 Plant metabolite exporter gene promoters |
| 04/02/2009 | US20090089895 Antifungal polypeptides |
| 04/02/2009 | US20090089894 Metacaspase II in engineering soybean for disease resistance |
| 04/02/2009 | US20090089893 Sucrose synthase 3 promoter from rice and uses thereof |
| 04/02/2009 | US20090089891 Transcription factor stress-related proteins and methods of use in plants |
| 04/02/2009 | US20090089889 Neuromedin u receptor subtype 1 deficient transgenic mice and uses thereof |
| 04/02/2009 | US20090089888 Sour/Acid Taste Receptors Assays, Genes and Proteins |
| 04/02/2009 | US20090088555 44 Human Secreted Proteins |
| 04/02/2009 | US20090088449 4-acylaminopyridine derivative mediated neurogenesis |
| 04/02/2009 | US20090088398 Recombinant adenoviral vectors and methods of use |
| 04/02/2009 | US20090088385 immunoglobulins; fibronectins; drug screening |
| 04/02/2009 | US20090088382 Use of the cathelicidin LL-37 and derivatives therof for wound healing |
| 04/02/2009 | US20090088365 Biosynthetic Polypeptide Fusion Inhibitors |
| 04/02/2009 | US20090087909 Use of Trehalose in Conifer Somatic Embryogenesis to Increase Germination Vigor |
| 04/02/2009 | US20090087908 Methods for Stratification and Storage of Somatic Embryos |
| 04/02/2009 | US20090087907 Compositions and Methods for Growth of Pluripotent Cells |
| 04/02/2009 | US20090087906 Novel cell-based assays for g-protein-coupled receptor-mediated activities |
| 04/02/2009 | US20090087905 VEGF-D polynucleotides and methods of use |
| 04/02/2009 | US20090087889 Methods and compositions for growth hydrocarbons in botryococcus sp. |
| 04/02/2009 | US20090087883 Novel expression vector with enhanced gene expression capacity and method for using the same |
| 04/02/2009 | US20090087881 Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same |
| 04/02/2009 | US20090087878 polypeptide useful for production of plant growth regulators; herbicides and heat tolerance |
| 04/02/2009 | US20090087877 Infectivity assay |
| 04/02/2009 | US20090087876 Methods and compositions useful for modulating drug-induced impairment |
| 04/02/2009 | US20090087865 Monoclonal Antibodies to Tacrolimus and Immunoassays Methods for Tacrolimus |
| 04/02/2009 | US20090087851 Lineage-Restricted Neuronal Precursors |
| 04/02/2009 | US20090087493 Supramolecular Functionalization of Graphitic Nanoparticles for Drug Delivery |
| 04/02/2009 | US20090087481 Using mixture comprising colony stimulating factor, interleukin-5 and/or a mimetic as therapeutic tool in treatment of nervous system disorders |
| 04/02/2009 | US20090087474 Therapeutic use of growth factors,nsg29 and nsg31 |
| 04/02/2009 | US20090087472 Controlled release of biopharmaceutical growth factors from hydroxyapatite coating on bioresorbable interference screws used in cruciate ligament reconstruction surgery |
| 04/02/2009 | US20090087471 Method of treating tissue |
| 04/02/2009 | US20090087449 Novel Peptide Compositions and the Use Thereof, in Particular, in the Preparation of Active Pharmaceutical Compositions Against the Hepatitis C Virus |
| 04/02/2009 | US20090087445 Method for the Redox Potential-Dependent Detection of Target Molecules by Interacting Polypeptides |
| 04/02/2009 | US20090087440 Methods for Treating Cancer |
| 04/02/2009 | US20090087439 Compositions and methods for diagnosing or treating psoriasis |
| 04/02/2009 | US20090087438 Anti-tsg101 antibodies and their uses for treatment of viral infections |
| 04/02/2009 | US20090087437 Methods and compositions relating to the regulation of apoptosis by muc1 and bh3-containing proapoptotic proteins |
| 04/02/2009 | US20090087435 Isolated Chimeric Proteins Of Modified Lumazine Synthase |
| 04/02/2009 | US20090087430 Selective inhibition of toll-like receptor-2 |
| 04/02/2009 | US20090087429 IL-17 homologous polypeptides and therapeutic uses thereof |
| 04/02/2009 | US20090087428 Anti-fc-gamma riib receptor antibody and uses therefor |
| 04/02/2009 | US20090087427 Biological materials and uses thereof |
| 04/02/2009 | US20090087417 Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands |
| 04/02/2009 | US20090087416 novel B7-H3 and B7-H4 polypeptides useful for co-stimulating T cells, vectors containing the nucleic acid molecules, and cells containing the vectors |
| 04/02/2009 | US20090087414 Materials and methods for altering an immune response to exogenous and endogenous immunogens, including syngeneic and non-syngeneic cells, tissues or organs |
| 04/02/2009 | US20090087411 Long-acting interferons and derivatives thereof and methods thereof |
| 04/02/2009 | DE102007044487A1 Verwendung des umgekehrten Zelldifferenzierungsprogramms (OCDP) zur Behandlung degenerierter, im pathologischen Zustand befindlicher Organe Using the reverse cell differentiation program (OCDP) for the treatment of degenerate, properties under pathological state organs |
| 04/02/2009 | CA2701668A1 Factor involved in latent infection with herpesvirus, and use thereof |
| 04/02/2009 | CA2701034A1 Cell rolling separation |
| 04/02/2009 | CA2700986A1 Anti-glypican-3 antibody having improved kinetics in plasma |
| 04/02/2009 | CA2700942A1 An ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases |
| 04/02/2009 | CA2700926A1 Methods for modulating the proliferation and differentiation potential of stem cells and progenitor cells |
| 04/02/2009 | CA2700701A1 Method of modifying isoelectric point of antibody via amino acid substitution in cdr |
| 04/02/2009 | CA2700618A1 Inhibition of dendritic cell-driven regulatory t cell activation and potentiation of tumor antigen-specific t cell responses by interleukin-15 and map kinase inhibitor |
| 04/02/2009 | CA2700613A1 Angiogenic cells from human placental perfusate |
| 04/02/2009 | CA2700500A1 Desiccated biologics and methods of preparing the same |
| 04/02/2009 | CA2700371A1 Method for creating perfusable microvessel systems |
| 04/02/2009 | CA2700364A1 Method for creating perfusable microvessel systems |
| 04/02/2009 | CA2700170A1 Genomic editing in zebrafish using zinc finger nucleases |
| 04/02/2009 | CA2699976A1 Apparatus for and method of preparing plant tissue for plant production |
| 04/02/2009 | CA2697583A1 Antidotes for factor xa inhibitors and methods of using the same |
| 04/01/2009 | EP2042869A2 High affinity TCR proteins and methods |
| 04/01/2009 | EP2042606A1 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic use |
| 04/01/2009 | EP2042603A1 Phosphonate metabolizing plants |
| 04/01/2009 | EP2042602A1 Cosmid vector for plant transformation and use thereof |
| 04/01/2009 | EP2042601A1 Novel variant EGIII-like cellulase compositions |
| 04/01/2009 | EP2042600A1 A public and immunogenic CD4+ T Cell epitope of the hiv tat protein and its applications |
| 04/01/2009 | EP2042596A1 Polypeptides involved in immune response |
| 04/01/2009 | EP2042594A1 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 04/01/2009 | EP2042592A1 Methods for modulating the proliferation and differentiation potential of stem cells and progenitor cells |
| 04/01/2009 | EP2042591A1 Erythropoietin-producing organoid precursor, method of constructing the same and method of treating erythropoietin-related disease |
| 04/01/2009 | EP2042518A2 Dual specificity antibodies and methods of making and using |
| 04/01/2009 | EP2042509A1 Modulators of the function of FAS receptors and other proteins |